Since copanlisib was previously shown to cause apoptosis by inhibiting the antiapoptotic protein Bcl-xL in breast cancer cells21, apoptosis and cell cycle were assessed to determine their respective contribution to determine the effect of copanlisib in HCC cells. This evidence concerns the gene BCL2L1 and breast carcinoma.